Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Brazil: Wayde’s dream destination since childhood
2015-12-15


Wayde van Niekerk knows he has to work even harder in 2016 if he wants to achieve success at the Olympic Games in Rio de Janeiro. Photo: Charl Devenish

When he was still in primary school, Wayde’s dream destination was Brazil. Even his dog’s name is Rio.

So it almost seems written in the stars for Wayde van Niekerk to take part in the 2016 Olympic Games in Rio de Janerio.

According to the 400m athlete of the University of the Free State (UFS), the Olympics has been something he has been dreaming about for years.

Van Niekerk, who studies BA Marketing at the UFS, has had a phenomenal 2015 season, and the whole of South Africa hopes he can repeat his outstanding form in Rio. The Olympics will be held from 5-21 August 2016.

Funny story

“It actually is a funny story. You know when you are in primary school, and the teacher says you have to write down your dream destination. Mine was Brazil,” Van Niekerk revealed.

“In 2012 at the closing ceremony of the London Olympics, I saw they introduced Rio as the next hosting country, and I thought Wow! That is where I want to be, and what I want to do.

“That opened my eyes and I knew God has a plan for me. I have to put in the hard work and achieve something with my life. Luckily from there on, there was pure growth in my life and I am grateful for that.”

His dream is also carried by his dog, Rio, a husky he got about two years ago.

Preparation in 2016

Van Niekerk will follow a specific programme leading up to Rio 2016.

In February next year, he will still be taking things easy, but will probably compete for the UFS in the Varsity Sports athletics.

“You have to build up slowly to peak at the right time,” he said.

In June 2016, he will start competing internationally in Jamaica, then New York, the All-Africa Games in Durban, and then,  some Diamond League events before the Olympics in August.

In the archive:

KovsieSport star

NBC tells waydes story

Wayde nominated as SAs best

Wayde Adidas face

Wayde’s hat trick of awards

Congratulate wayde and other achievers

Wayde wins gold

Kovsie trailblazing track runner

Kovsie gold medalist

Kovsie Campion sprinter

Wayde sets African record

Kovsies keep winning, this time in athletics

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept